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Abstract
Background: The World Health Organization (WHO) aims to promote strategies that ensure efficacy, safety, suitability, and 
cost-effectiveness of medicine prescription. Health systems should design effective mechanisms to monitor prescription 
and rational use of medicines at all healthcare settings. This study aimed to determine and analyze prescription patterns 
of general practitioners and specialists in Kerman/Iran from 2005 to 2015.
Methods: This is an explanatory mixed method study. Data were gathered during two phases. At the first phase, 
prescriptions issued by physicians during 2005-2015 were reviewed to extract information required to develop eight main 
prescription indicators. In the second phase, the indicators trends were presented to experts participating in expert panel 
to have their opinions and analyses on the data obtained in the first phase. Experts were selected based on their experience 
and expertise in medicine and/or health policy and/or experience in implementation of polices to promote rational use of 
medicines. Some experts attending the panel were a sample of physicians whose prescriptions were included in the first 
phase. 
Results: Findings revealed that two indicators of the average price of prescriptions and the maximum number of medicines 
in each prescription had an increasing trend over the study period. Reasons including unprecedented devaluation of the 
Iranian Rial and willingness of young physicians to prescribe more medications were proposed as the primary contributors 
to the observed increasing trends. However, other indicators including types of prescribed medicines, average number of 
medicines per prescription, the percentage of prescriptions with more than four medications, a percentage of encounters 
with a corticosteroid prescribed, a percentage of encounters with an antibiotic prescribed, and a percentage of encounters 
with an injection prescribed decreased in the study period. Reasons of controlling initiatives adopted by the Ministry of 
Health, the higher responsibility of physicians, adoption of continued medical education (CME) programs, and improved 
knowledge of pharmacists, physicians, and patients about irrational use of medicines were proposed by participants as the 
main reasons for the decreasing trend. 
Conclusion: Findings indicated that prescription indicators were better in Kerman than those of country average over 
the study period based on comparing the results of this study and others in Iran. However, they were non-desirable when 
compared to the international average. The number of factors contributes to the irrational use of medicines, including lack 
of knowledge among healthcare providers and patients, patients’ misunderstanding about the efficacy of some particular 
medicines, the high cost of drug development and manufacturing, and unavailability of effective medicines.
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Background
Establishment of an effective pharmaceutical management 
system is one of the most important goals of health systems 
worldwide.1 The World Health Organization (WHO) aims 
to promote strategies that ensure efficacy, safety, suitability, 
and cost-effectiveness of medicine prescription. Medicine is a 
strategic product of concern to all countries in such a way that 
a large proportion of discretionary health expenditures in both 
developed and developing countries allocate to procurement, 
distribution and consumption of medicines.2,3 Considering 
their functions, health systems are not only responsible for 
providing equitable access to medicines, but also they should 
design effective mechanisms to monitor the prescription and 
rational use of medicines at all settings of healthcare.4
WHO defined rational drug perception as “patients receive 
medications appropriate to their clinical needs, in doses that 
meet their individual requirements, for an adequate period of 
time, and by the lowest cost to them and their communities.”5,6 
WHO and the International Network Rational Drug Use 
(INRUD) have proposed a number of indicators to assess 
rational use of medicines. These indicators are widely accepted 
as an objective standard to measure quality of medicines 
utilization and prescription behavior in health facilities.5
Inappropriate use of medicines can have adverse effects on 
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Implications for policy makers
Our mixed-method study showed that using experts’ opinion can improve interpretation of data on medication utilization. Furthermore, some 
interventions may promote rational use of medicines (The rational of medicines usage emphasizes on the rational prescription of drugs by practitioner 
and specialists and also rational use of prescribed drugs) as follows:
• Regulate drug market to replace non-effective or unsafe medicines with more effective medications and to include different medications’ types 
and forms,
• Providing physicians with feedback on their prescription patterns,
• Provide education on rational prescribing to medical students,
• Updating physicians’ knowledge on rational prescribing through continued medical education (CME) programs, and
• Providing educational massage on medication utilisation for population. 
There are some factors that can be effective in drug trends that policy maker should consider, including:
• Economic conditions of the society and changes in the price of pharmaceutical drugs,
• Measures taken by the Ministry of Health and Medical Education (MoHME) in controlling and monitoring the drug market,
• Changing the pattern of diseases and increasing the burden of chronic diseases,
• Behaviours and motives of doctors, and
• Patient behaviours and thoughts.
Implications for the public
The rational of medicines usage emphasizes on the rational use of antibiotics, corticosteroids and injecting medications. The analysis shows that 
consumption of these medicines has decreased over an eleven-year period in Kerman province. It seems that initiatives adopted by Ministry of 
Health and Medical Education (MoHME) and providing physicians with continued medical education (CME) programs were among the main 
factors contributing to the reduction. In the time that it decreased in trends, mostly all the parameters were fixed except the MoHME intervention 
and experts believed that these interventions were effective. 
Key Messages 
health costs. In one hand, inappropriate use of medicines can 
adversely jeopardize quality of medical care and influence 
treatment outcomes. It can also lead to antimicrobial 
resistance. On the other hand, higher costs of pharmaceutical 
products along with technical dependency of pharmaceutical 
industry to developed countries may lead to either dependence 
on medicinal imports or permanent and temporary shortage 
of some types of medicines.2,7 
Evidence shows that from 2005 to 2011, per capita 
consumption of tablets and capsules increased from 367 to 
432 ones in Iran, indicating of a 17.7% increase in medication 
use. However, it seems that the best way to control irrational 
use of medicines is through prescription management.8 
Studies have shown that the average number of drug per 
prescription among Iranian physicians is 3.07, which is higher 
than the standards recommended by WHO that is between 
1.3 to 2. This is also true for antimicrobials and intravenous 
drugs, indicating that the high prescription and consumption 
of medicines in Iran is way higher than of recommended 
international standards.9,10 The study in one of the Iranian 
cities (Isfahan) showed that the administration of antibiotics 
and injectables in the prescriptions of physicians is common 
and inadequate.11
This study aimed to determine and analyze prescription 
patterns of general practitioners and specialists in Kerman 
province from 2005 to 2015. Iran’s Ministry of Health 
and Medical Education (MoHME) has developed a set of 
indicators including indicators developed jointly by WHO 
and INRUD and indicators suggested by for rational use 
of medicines. This set of indicators are used for this study. 
In order to achieve a deeper analysis of the changes in the 
prescription trend over that 11 years, and to better identify 
influential factors,  quantitative results were combined by 
qualitative exploration of experts’ opinions. 
Methods
This is an explanatory mixed method study. Mixed method 
studies provide researchers with opportunities to triangulate 
their findings with different sources of information. As 
follows, two phases of data collection and analysis were 
undertaken:
Gathering Quantitative Data and Analyzing Indicators Trends
During this phase, prescriptions written by physicians during 
2005-2015 were reviewed to extract information required 
to develop the eight main indicators of (1) average price of 
prescriptions, (2) types of prescribed medicines, (3) average 
number of medicines per prescription, (4) maximum number 
of medicines per prescription, (5) percentage of prescriptions 
with more than four medicines, (6) percentage of encounters 
with a corticosteroid prescribed, (7) percentage of encounters 
with an antibiotic prescribed, and (8) percentage of 
encounters with an injection prescribed. These indicators 
are selected because the Ministry of Health has determined 
these indicators, collects data for them, and monitors them 
systematically.
Currently, prescriptions of patients received in pharmacies 
are electronically sent to insurance companies and then sent 
to the Food and Drug Administration. All electronic data are 
imported in the software of “Noskheh pardaz.” We have used 
this software data for our study indicators and investigating 
the trends. Data was analyzed using SPPS software version 16.
Expert Panel and Analysis of Indicators Trends
The aim of this phase was to present the indicator’s trends 
to experts participating in the expert panel to have their 
point of view and their analysis on results obtained from 
the first phase. The experts were from different disciplines 
including health management and economics, medicine, and 
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pharmaceutical industry. For our expert panel we selected the 
experts by different disciplines and specialties to investigate 
the issue from different aspects. For example we had general 
practitioner and specialist to realizing their prescription 
behavior. We had also experts from health management 
and economics, medicine, and pharmaceutical industry for 
realizing and considering the socio economic factors. And 
also we had experts from insurance as the key stakeholder and 
the importance of drugs supported by insurance. Experts were 
selected based on their experience and expertise in medicine 
and/or health policy and/or experience in implementation of 
polices to promote rational use of medicines. Table 1 shows 
the demographic characteristics of the participants. To create 
a balance between topics in group discussions, participants 
were selected using a proportional sampling method.12 
At the beginning of group discussions, the participants were 
presented the changes happened in prescriptions over the 
study period. Participants, then, were asked to express their 
views on the causes and factors influencing the changes in 
indicators, and to propose strategies to improve rational use 
of medicines in the future. Overall, two expert panels were 
conducted with 20 experts. All conversations were digitally 
recorded with the permission of participants and transcribed 
verbatim. 
The framework analysis method consisting of ﬁve main 
steps (familiarization, identifying a thematic framework, 
indexing, charting and mapping, and interpretation) was 
used to analyze qualitative data. Incorporating inductive and 
deductive elements, this method is becoming an increasingly 
popular approach in health policy research.13
During familiarization step, a summary of the content of each 
interview was created. The initial thematic framework was 
developed by the research team members. The transcripts were 
checked against thematic framework through a familiarization 
step. Then transcribed interviews were initially indexed by 
one of the authors. Coding was veriﬁed by other authors 
and disagreements were resolved through discussion. Data 
were coded and categorized using MAXQDA 10 software. 
In charting stage, a chart was produced for each theme. All 
data were transferred to these charts to produce the analysis 
chart. Themes were written up describing the similarities and 
variations between participants. Finally, in the mapping and 
interpretation step, the charts were reviewed by all the authors 
to make sense of the entire data set.
Results
The initial results showed an increase in the total number of 
prescriptions during those years. Table 2 displays the total 
number of reviewed prescriptions by general practitioners and 
specialists from 2005 to 2015 in Kerman. Further, the number 
of prescriptions by general practitioners and specialists were 
always equal and the increase or decrease in different years 
had a relatively same trend (Figure 1). 
In the current study, simultaneous gathering and analysis 
of data at two phases allowed the authors to identify and 
investigate indicators’ trends from 2005 to 2015, shown in 
Table 3. This matter will be explained in the below.
Average Price of Prescriptions 
The following figure shows that the trend of prescriptions 
price has risen over the 10-year period that has intensified 
since 2011. Experts’ analysis was that this rise was due to the 
influence of inflation, which affected the Iranian economy 
in last 10-year period: “Since 2011, we have witnessed an 
increase in the price of medicines in the country due to dramatic 
devaluation of national currency versus US dollar…, the price 
of some medicines, compared to the past, have increased 
several folds, which has put a fiscal pressure on both the health 
system and people…” (R2). To test this hypothesis, by using 
the inflation rates in this 10-year period, the expected prices 
Table 1. Location and Number of Interviewees at Each Organization
Organization Organizational Role No. of Participants
Kerman University of Medical Sciences Officials 
(KMO)
Deputy director for food and drug
4
Director of think tank
Dean of the Faculty of Pharmacy
Research and Development Department of the Food and Drug Administration
Managers and experts from the health insurance 
offices in Kerman province (HI)
Provincial officials and experts of health insurance 4
Healthcare provider (HR) General practitioner (GP), specialist (SP), pharmacist (PH) 6
Researchers (R) Experts Food and Drug Department, Researchers in the fields of Health Economics, 
Healthcare Management and Health Policy
6
Total 20
Table 2. Total Number of Prescriptions From 2005 to 2015
Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
No. of prescriptions by general 
practitioners 
- 484 539 559 671 903 596 789 1 039 065 1 170 248 940 367 972 848 832 887 920 842
No. of prescriptions by 
specialists
- 1526 581 071 677 565 588 080 1 106 817 1 253 871 980 897 1 047 210 873 081 969 821
The total No. of prescriptions  19 382 2010 1 120 630 1 349 468 1 184 869 2 145 882 2 424 119 1 921 264 2 020 058 1 705 968 1 890 663
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were calculated with the annual inflation rate (which is shown 
by double line in Figure 2). As noted above, for most of this 
period years, the observed prices are close to the expected 
price levels. Therefore, it can be said that the main part of 
price changes is justified by the trend of annual inflation rate 
changes.
An increase in price of raw material in the pharmaceutical 
sector was the other reason mentioned for the increase in 
average price of medicines: “The government somehow controls 
inflation rate in the pharmaceutical sector, but following the 
increase in factors such as price of raw materials, staff costs 
(Iranian worker’s costs), transport costs and so on, the price 
of medicines increased by 16 to 18% annually, a considerable 
increase which can be seen in the trends as well” (KMO1). 
Types of Prescribed Medicines 
This indicator shows the quantity and variety of prescribed 
medicines, or in other words, the pharmacopoeia of 
physicians. The type of drug indicator shows the number 
of the drugs that doctors prescribe. It shows the medicines 
that are in the doctor’s pharmacopeia. A higher range of 
prescribed medicines included more effective medicines with 
no side effects indicates of better knowledge and expertise of 
physicians. The data showed that while prescribed medicines 
had the narrowest verity in 2005, it had the widest variety 
in 2009. However, since 2009, the indicator has decreased 
gradually (Figure 3). The experts considered initiatives 
adopted by MoHME aimed at removing some unnecessarily 
or harmful medicines from market as the reason for this 
issue: “Since 2009, the MoHME has introduced some sorts of 
initiatives to control available medicines in the market, which 
has contributed to the reduction in prescription of medicines 
that were harmful, ineffective, or excessively used previously” 
(KMO3).
Conversely, factors such as financial motivation and attempts 
made by physicians to have more clients led to decrease in the 
variety of prescribed medicines. : “It is discussed that medicine 
is a business and in our society, patients expects doctors to treat 
them at the first visit... it is not possible to behave scientifically 
and start from the primary level, and in the case of lack of 
improvement, then refer patient to the secondary level and 
change drugs gradually. Physicians, at the first time, prescribe 
a strong medicine, due to patient request and in order to treat 
the patient rapidly, without considering possible side effects, 
[By following this approach, in the end, patient assumes the 
physician of high competence and skills]...” (KMO2).
Table 3. Prescription Quality Indicators (2005-2015)
Indicator
Year
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Average price of prescriptions (IRR) 22 537 20 365 31 263 28 860 38 719 40 107 44 228 51 635 71 959 86 717 106 877
Number of prescribed medicines 342 1033 1414 1418 1726 1618 1525 1463 1305 1475 1405
Average number of medicines per prescription 3.28 3.38 3.10 3.04 3.00 2.94 2.88 2.83 2.78 2.81 2.81
Maximum number of medicines per prescription 9 12 14 13 23 14 17 14 12 13 14
Percentage of prescriptions with more than four 
medicines 
14% 17% 13% 12% 12% 11% 10% 9% 9% 9% 10%
Percentage of encounters with a corticosteroid 
prescribed
0 0 0 0 17% 16% 16% 16% 15% 16% 14%
Percentage of encounters with an antibiotic 
prescribed
0 0 0 0 45% 44% 43% 41% 38% 40% 39%
Percentage of encounters with an injection 
prescribed
29% 39% 30% 30% 28% 27% 29% 28% 28% 27% 26%
Figure 1. The Total Number of Drug Prescriptions by General Practitioners and Specialists (2005-2015).
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Average Number of Medicines Per Prescription
This indicator shows the number of medicines prescribed 
per patient visit. The experts believed that the high values of 
indicator can make healthcare systems to spend excessively 
on pharmaceuticals and waste financial resources: “Both 
MoHME and our organization (health insurance organizations) 
consider the decreased number of medicines [prescribed by 
doctors] as a positive point, while such a decrease is regarded as 
an unpleasant and negative condition by some patients. They 
think as ‘the more, the merrier’” (HI2).
Findings of this study revealed a gradual decrease in the 
average number of medicines per visit from 2005 to 2015 
(Figure 4). The experts asserted that an increased sense 
of responsibility among physicians towards public health 
resulted in that they consider safety and suitability of drug 
while prescribing. Moreover, increased awareness of the 
patients about medicine overuse and side effects was proposed 
as another main reason for such a decrease: “Fortunately, 
during recent years, responsible bodies have tried to promote 
the belief that excessive use of medications is not always good 
and can cause other problems. It seems that the beliefs have 
changed over time and this issue resulted in decreased demand 
for medicines” (PH4).
However, factors such as writing more than one prescription 
per visit was identifies as another reason for such a decrease: 
“One of our problems is that some physicians do not write all 
prescribed drugs in just one prescription. They know we (health 
insurance organizations) are monitoring their prescribed 
medicines. So they write medicines in two or more prescriptions 
separately” (HI4).
As adopted initiatives by the MoHME has led to a decrease in 
the variety of medicines prescribed, these interventions have 
also had some impacts on the average numbers of medicines 
per visit and decreased it. Conversely, it is highly probable that 
factors such as increased burden of chronic diseases may have 
led to a relatively high increase in the indicator: “Currently, 
the prevalence of chronic diseases such as Diabetes, metabolic 
syndrome, obesity, high blood pressure and so on is increasing, 
and sometimes when a physician visits a patient, he/she has to 
prescribe medicines for blood sugar, cholesterol and ..., these 
issues increase the average number of medicines prescribed per 
patient encounter as well” (SP4).
Figure 2. Average Price of Each Prescription.
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According to the participants, entrance of newly graduated 
physicians to the job market could also increase the indicator: 
“While reviewing [prescriptions] within the committee of 
prescription and consumption of medicines, we found out that 
older and more experienced physicians prescribe less drugs…; 
in contrast, recently graduated physicians prescribe more drugs 
with higher average of price” (KMO1). Lack of competence in 
rational prescribing skills among recently graduated physicians 
was raised as the reason for this issue by most of the experts: 
“We did not provide enough education on rational prescribing to 
medical students. I think if the principles of rational prescribing 
could be incorporated into their educational curriculums, many 
problems can be prevented or solved” (KM2).
The Maximum Number of Medicines Per Prescription
This indicator presents the maximum number of medicines 
prescribed by physicians within a certain period. It 
represents the highest number of drugs that doctors 
prescribed in their prescriptions. For example, if this 
indicator is 30, it means that in the year the largest number of 
drugs that are prescribed in a prescription is 30.  
Figure 4 shows the indicator’s trend between 2005 and 2015. 
The maximum number of medicines in a prescription belonged 
to year 2009, in which there were prescriptions including 23 
medications. Excluding 2009, an increasing trend was seen 
in the maximum number of medicines prescribed from 
2005 to 2015. The experts asserted that the high number of 
medicines prescribed by newly graduated physicians was the 
reason behind such an increase. They pointed out that since 
2009, when the number of recently graduated physicians 
increased in the province, there has been a gradual rise in 
the number of medicines per patient. In addition, migration 
of more experienced physicians from deprived provinces to 
better-off provinces can also be considered as another reason: 
“The problem of the majority of the southern provinces of the 
country, eg, Kerman, is that these provinces are usually selected 
by young physicians to undertake their community services. 
These physicians pass the initial period of their practice in these 
provinces and after getting experience, they usually migrate to 
larger cities and metropolitan areas such as Tehran, Isfahan, 
Shiraz, or Mashhad; this issue brings about many challenges for 
these provinces” (KMO 1).
Another factor that contributes to such an increasing trend is 
the shortage of combinatorial medicines and low diversity of 
medicines in the national pharmacopoeia: “A problem which 
we have is that the number of those medicines that cover several 
health conditions simultaneously is scarce. In other words, due 
to lack of effective medicines, physician has to prescribe several 
medicines for each condition, which definitely increases the 
indicator” (GP 1).
Percentage of Prescriptions With More Than 4 Medicines
The analysis of the data showed a decreasing trend in the 
percentage of prescriptions with more than 4 medications 
(Figure 5). Based on the experts’ opinion, the lower 
the indictor value, the more rational and appropriate 
prescriptions issued by physicians. A number of factors such 
as continued medical education (CME) programs designed 
by MoHME and universities of medical sciences to improve 
physicians’ competence in rational prescription were raised 
as contributors to the decreasing trend: “CME courses held by 
universities attempted to make prescription more rational. The 
courses led to increased knowledge and skills [regarding rational 
prescription] among physicians as well as a decreased number 
of medication errors” (R4).
An increase in physicians’ awareness of drug interactions, 
which can be a result of the CME programs, was identified 
as an important factor in reducing the indicator: “Fortunately, 
physicians now have more knowledge and awareness about the 
types of drugs available in the market and possible drug-drug 
interactions, and this was one of the reasons for this decrease” 
(SP2).
Percentage of Encounters With a Corticosteroid Prescribed
The analysis showed that during the recent years this indicator 
trend was fairly constant, showing a slight decrease (Figure 
5). The increasing medical and pharmaceutical community’s 
awareness about the side effects of the excessive use of these 
medicines was considered as the reason for this trend by the 
experts: “The Ministry of Health warned that by continuing the 
use of corticosteroid medicines, a disastrous rate of osteoporosis 
will soon show up among women taking these medicines. 
Besides, Kerman University of Medical Sciences [KUMS] has 
implemented several programs to inform people about the risks 
of these medicines, particularly Dexamethasone, which causes 
false obesity. I think these programs could gradually decrease 
Figure 4.  Average and Maximum of Medication Items Prescribd in Physicians’ Prescriptions.
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the prescription of these medicines” (PH2). Poor availability 
of proper alternative medicines in pharmacopeia and limited 
insurance coverage of alternative medicines were proposed 
as some reasons for high use of these medications. These 
factors encourage physicians to use more Corticosteroids: 
“One of the reasons for the widespread use of Corticosteroids 
in Iran is unavailability of suitable analgesic medicines in 
pharmacopeia. Besides, the available [alternative] medicines 
are not fully covered by health insurance schemes. For this 
reason, some general practitioners use corticosteroids to 
decrease inflammation and pain in patients” (KMO3).
Percentage of Encounters With an Antibiotic Prescribed
The findings showed a decreasing trend in the percentage 
of visits with an antibiotic prescription over the recent 
years (Figure 5). Regulatory initiatives adopted by MoHME 
along with increased awareness of physicians concerning 
antimicrobial resistance, caused by overuse of antibiotics, were 
considered as the main reasons for the decreasing trend: “The 
high use of these medicines causes drug resistance and when 
it (drug resistance) occurs we have to use stronger antibiotics; 
Stronger antibiotics are usually more expensive; Therefore, 
the average price of each prescription and the percentage of 
patients receiving injecting drugs will also increase...Thus if we 
continue this trend, we will enter into a vicious circle, which 
can have very dangerous consequences for public health. I think 
nowadays most of the physicians have accepted this issue” (R5).
Nevertheless, there were some factors mentioned which in 
turn could increase the prescription of these medicines: “It 
is likely that the low revenue of some physicians encourages 
them to prescribe medicines requested by patients in order to 
have more future patients... These physicians assume that they 
must prescribe medicines which decrease pain of patients and 
prevent future infections; this issue can increase the prescription 
of antibiotics” (GP 1).
It should be mentioned that due to information deficiency, it 
was not possible to investigate the trend of percentage of visits 
with an antibiotic and corticosteroids prescribed from 2005 
to 2008, but these indicators have gradually decreased since 
2008 (Figure 4).
Percentage of Encounters With an Injection Prescribed
The data revealed that this indicator had a relatively constant 
trend with a slight decrease over the study period (2005-2015) 
(Figure 5).
Participants believed that due to different reasons such as high 
costs, painful administration, and probability of infection, it 
is better to reduce the use of injections. In this regard, one 
of the specialists stated that: “Generally, from a health system 
perspective, prescriptions including injecting medicines usually 
have high costs. From patients’ side, cost of injection in addition 
to the pain of injection and sometimes problems such as 
administration error or possible infection, encourage patients to 
lower the use of this form of medicines” (PH1).
Some of the participants pointed out that the increased 
awareness of physicians about side effects of injecting 
medicines has led to a reduction in prescription of these 
medications in recent years: “Currently, injecting medicines 
are not prescribed much; just special injecting antibiotics such 
as Penicillin are prescribed at low levels in medical offices, if a 
patient is too sick” (GP 2).
Most participants acknowledged that lack of information and 
wrong beliefs among patients threaten adherence to rational 
prescription: “There is a wrong culture among our people 
in which patients ask their physicians to prescribe certain 
medicines for them... this issue gets worse when our patients 
believe that injections are more powerful than oral medicines. 
Even some patients do not believe in a prescription in which 
there is no injecting medication and they do not adhere to it. It 
is also true about antibiotics, our people like antibiotics” (SP1).
Discussion
This study aimed to investigate rational use of medicines in 
Kerman province. To achieve this goal, eight main indicators 
of rational prescription were investigated over an 11-year 
period. The indicators investigated were as follows: average 
price of prescriptions, types of prescribed medicines, average 
number of medicines per prescription, maximum number of 
medicines per prescription, percentage of prescription with 
more than four medicines, percentage of encounters with a 
corticosteroid prescribed, percentage of encounters with an 
antibiotic prescribed, and percentage of encounters with an 
injection prescribed.
The findings showed that although the average number of 
medications per prescription has not increased much over the 
period, but the average price of prescriptions has increased. 
Figure 5. Percentage of Prescriptions With More Than 4 Medication Items, Percentage of Encounters With an Injection Prescribed, a Corticostroid 
Prescribed, an Antibiotic Prescribed.
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Increases in the price of law materials, devaluation of Iran’s 
national currency, and increases in the inflation rate (average 
12% annually)14 were among the reasons proposed by experts 
for such a trend. However, when the indicators trend was 
compared with the average price of prescriptions for all Iranian 
physicians, the indicator amounted to US$3.67 in Kerman 
and to US$4.28 in the whole country.8 Experts believed that 
one of the most important reasons for this phenomenon was 
that physicians practicing in Kerman were much younger 
than the average of all Iranian physicians. A study conducted 
in India showed that despite adoption of the control measures 
by regulatory bodies, the average price of prescriptions was 
increasing. That study proposed to move towards greater 
use of generic drugs instead of brand drugs to control the 
increasing trend.15 In addition to irrational prescriptions that 
lead to increases in healthcare costs, evidence show that cost of 
drug production and supply, compared to other components 
of the health system, has witnessed a significant growth since 
1990s. Factors such as increases in R&D expenditures within 
pharmaceutical companies and the emphasis on development 
of new drugs play major roles in the increasing trend. In 
addition to the costly process of new drug development, 
other factor such as effects of governmental policies on 
drug market or willingness of insurance companies to cover 
the newly developed medicines should be considered while 
investigating factors influencing costs.16
Our results confirmed the high degree of diversity in 
prescribed medicines by physicians in Kerman. However, 
in 2011, the indicator value was 1525 medicines in Kerman 
and 3490 at the national level.8 This difference indicates that 
limited range of medicines prescribed by Kerman physicians 
over the study period, which could result from limitations 
in the coverage of pharmaceutical drugs by health insurance 
schemes. In addition to factors like commercialization of 
medicines, regulatory initiatives taken up by MoHME that aim 
to omit harmful medicines from the market can be regarded 
as other influencing factors here. Researchers believe that to 
reduce antimicrobial resistance, rational and balanced use of 
various types of antimicrobials is much better than reduction 
in intake of one type of antibiotics.17 
The average number of medicines per encounter had a gradual 
decreasing trend during the eleven years. This study showed 
that several factors such as increased sense of responsibility 
among physicians and increased awareness of patients 
regarding overuse of medicines had reduced the overuse of 
medicines in recent years. According to WHO and INRUD, 
the recommended value for this indicator ranges from 1.6 to 
1.8 items.9,18 However, the minimum value of the indicator 
was reported to be 2.7 in the current study, ranging from 2.7 to 
3.3. Interestingly, the indicator value in Kerman province was 
lower than the country average (approximately 3 medicines).8 
Typically, the average value of this indicator fluctuates 
between 4.1 to 4.8 in developing countries and between 2.2 
to 3.1 in developed countries.11 A study conducted in seven 
Southeast Asian countries reported that the average ranged 
from 1.4 to 3.8 medicines per encounter.19
The findings showed that the maximum number of medicines 
prescribed by Kerman physicians had increased over the 
study period. Experts believed that lack of knowledge among 
young physicians and lack of combinatory drugs in the 
pharmacopoeia were the main reasons for such an increase. 
The indicator value was 17 in Kerman and 31 in the country, 
indicating of a better situation for Kerman.8 A study conducted 
in Iran/Isfahan, reported that general physicians prescribed 
more number of medicines per patient as compared to 
specialists.11 Prescription of too many medications per 
encounter can be due to various reasons including, economic 
incentives, low knowledge about appropriate prescription, 
and lack of effective medicines.18
Percentage of prescriptions which had more than 4 
medications showed a decreasing pattern in the current study, 
ranging from 9% to 17%. In 2011, this indicator was reported 
to be 10% for physicians practicing in Kerman province 
that was lower than the country average (15%) in the same 
year.8 Due to complications resulted from improper use of 
drugs, an international movement in different countries has 
been begun to restrict medicines overuse. Rational use of 
medicines can be improved with measures such as patient 
education, physicians and pharmacists’ education, and 
adoption of regulatory interventions.20 Surely, such measures 
can reduce the percentage of prescriptions with more than 4 
items, improve the rational use, and reduce potential drug 
interactions. 
The findings of this study indicated that factors such as 
increased awareness of healthcare providers about adverse 
effects of corticosteroids has led to the stabilization or even 
decrease in the prescription of such medicines. The indicator 
in Kerman province (9%-12%) was much lower than the 
country average (23%).10 Experts believed that efforts made by 
KUMS along with regulatory measures instituted by MoHME 
were effective in reducing the indicator.
The findings showed that similar to corticosteroid medicines, 
use of antimicrobial medicines has decreased over that 
period. This decreasing trend might be due to the regulatory 
measures taken up by MoHME, increased awareness of 
antibiotic resistance, and promotion of responsible usage of 
antibiotics by physicians. WHO has warned about antibiotic 
resistance that has resulted from overuse of antibiotics and 
called it as a threat to global public health that requires actions 
across all governmental and societal sectors.21 
The ratio of antibiotics used per prescription, suggested by 
WHO, should not be more than 30% of all prescriptions.9 
However, in the current study it ranged from 38% to 45%. In 
2011, the ratio of antibiotics used per prescription was 45% in 
Kerman, which was equal to the country average in the same 
year.10 Prevalence of infectious diseases in underdeveloped 
and developing countries has led to high consumption of 
antimicrobial medicines in these countries. In this study, the 
proportion of antibiotics used was lower than that of other 
developing countries such as Sudan (71.8%), Ethiopia (58%), 
India (63.3%), and Nigeria (72.8%), and higher than some 
countries like Saudi Arabia (20%).18,22-24 A study conducted 
in Chinese hospitals to investigate prescription patterns 
reported that the average percentage of antibiotics usage was 
29.90%, which was mostly attributed to regulatory mandates 
adopted by hospitals and the government.9
In our study, the average percentage of injection usage varied 
from 27% to 39%, which was slightly lower than the national 
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average (41%).10 However, such a figure is far from the WHO 
standards (10%), which could indicate of a major deficiency 
of our health system.9 Factors such as increased awareness 
among physicians and high costs were raised by the experts as 
factors contributing to the observed decrease in the indicator. 
However, the experts believed that one of the main obstacles 
in rational use of injections was wrong beliefs among patients 
about the effectiveness of injection therapies and their 
irrational request for injection prescriptions. Another reason 
for irrational use of injection medicines was lack of coverage of 
effective medicines by basic health insurance that encouraged 
physicians to prescribe less effective drugs.25,26 In addition to 
high costs imposed to the health systems, irrational use of 
injectable drugs increases the incidence of infectious diseases, 
such as hepatitis and AIDS that incurs more costs to health 
systems in future.5 The value of this indicator in neighboring 
countries such as Bahrain, Kuwait and Saudi Arabia is 3.8%, 
1.9% and 2%, respectively.27-29
The present study had some limitations that should be borne 
in mind when interpreting the results. One of the limitations 
was lack of inclusion of patients and their families, as one of 
the main stakeholders of pharmaceutical industry, into the 
study. However, due to lack of access to patients who could 
express their concerns, physicians were considered as the 
representatives of patients in the study.
The main strength of this study was the use of a mix-method 
approach to investigate the 11-year trend of prescription in 
Iran. Recruitment of variety of stakeholders and experts, ie, 
general practitioners, specialists, representatives of insurance 
organizations, MoHME and University officials, healthcare 
management and policy experts and researchers, who 
participated in the expert panel, was another strength of the 
study. 
Conclusion
This mixed method study investigated prescription indicators 
and trends among general practitioners and specialists in 
Kerman from 2005 to 2015. The findings indicated that these 
indicators were better in Kerman when compared to country 
averages. Experts cited several reasons for these differences. 
Initiatives adopted by Kerman University of Medical Sciences 
(KUMS), Kerman, Iran to provide training about rational 
prescription for physicians as CME programs as well as 
promotion of rational medication use among the public 
were considered as effective measures to control irrational 
medicine use. It should be noted that there is at least one 
university of medical sciences in all Iran’s provinces and they 
are responsible to provide healthcare in their catchment area. 
In fact, these universities should take a more active role in 
assessing and monitoring the extent of rational medicine 
use, comparing differences across health facilities, analyzing 
changes over time, and evaluating interventions.
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